Latka logo
PathoQuest logo

PathoQuest

Paris, Ile-de-france, France

2024 Revenue

$5.9M(Est.)

Funding

$24.1M

Team

56

Founded

2010

PathoQuest Revenue & Funding (2024)

Developer of a molecular diagnostics technology designed to improve pathogen detection in biological samples. The company's technology combines sample preparation technology and cloud-based bioinformatics which is applicable to several types of samples with a proprietary pathogen genome sequence database and automated analysis pipeline, enabling doctors to improve the breadth of pathogen detection.

Last updated

PathoQuest Revenue

In 2024, PathoQuest's revenue reached $5.9M. The company previously reported $4M in 2023. Since its launch in 2010, PathoQuest has shown consistent revenue growth.

PathoQuest Revenue GrowthReported revenue / ARR over time · latest figure estimated$0$1.3M$2.5M$3.8M$5M$6.3M20102012201420162018202020222024$0$3.1M$5.9MSource: GetLatka.com
YearMilestoneSource
2024PathoQuest Hit $5.9m revenue in October 2024Estimated
2023PathoQuest Hit $4m revenue in October 2023Estimated
2021PathoQuest Hit $3.1m revenue in April 2021
2010Launched with $0 revenue

PathoQuest Valuation, Funding Rounds

PathoQuest has not publicly disclosed its valuation. The company has raised $24.1M in total funding to date.

PathoQuest has raised $24.1M in total funding across 5 rounds, with its most recent round in 2019.

PathoQuest Capital Raised & ValuationCumulative capital raised and post-money valuation by roundCapital raised (cum.)Valuation$0$0$0.2$6M$0.4$12M$0.6$18M$0.8$24M$1$30M201020122014201620182019Source: GetLatka.com
YearRoundAmountValuation% SoldSource
2019Funding round$9.8M--
2018Funding round$4.9M--
2015Funding round$2.4M--
2013Funding round$4.6M--
2011Funding round$2.4M--

Founder / CEO

Jean François Brepson

CEO

Jean-François Brepson has over 20 years leadership experience in the Pharmaceutical Industry. Prior to joining PathoQuest, Mr. Brepson was a Senior Vice-President at IPSEN where he was responsible for leading the global GI-Oncology & Endocrinology Franchise. He made a decisive contribution to the creation of leading portfolio in Neuro-EndocrineTumors in close collaboration with R&D and Business Development teams. He led the pre-launch of IPSEN first product in GI-Oncology on a worldwide basis. Prior to this, Mr. Brepson held several commercial operations positions at IPSEN including area Manager, BU Head, and General Manager in the EMEA region. Mr. Brepson has an Engineering Degree in Data Management System and a Master Degree in Foreign Trade. He has also earned "The Leadership & Innovation Certificate" for HEC in Paris and "The Blue Ocean Strategy Certificate" from INSEAD in Fontainebleau.

Q&A

QuestionAnswer
What's your age?-
Favorite online tool?-
Favorite book?-
Favorite CEO?-
Advice for 20 year old self-

Customers

We do not have customer count information for PathoQuest yet.

PathoQuest Employees & Team Size

PathoQuest employs approximately 56 people as of 2026, up from 47 in 2023, including 1 sales reps that carry a quota.

PathoQuest Team GrowthReported headcount over time0132538506320102012201420162018202020222024005656Source: GetLatka.com
YearMilestoneSource
2024Reached 56 employees (December 2024)
2024Reached 47 employees (October 2024)
2023Reached 47 employees (October 2023)
2022Reached 51 employees (October 2022)
2021Reached 44 employees (December 2021)
2021Reached 36 employees (April 2021)

Frequently Asked Questions about PathoQuest

What is PathoQuest's revenue?

PathoQuest generates an estimated $5.9M in annual revenue.

Who founded PathoQuest?

PathoQuest was founded by Jean François Brepson.

Who is the CEO of PathoQuest?

The CEO of PathoQuest is Jean François Brepson.

How much funding does PathoQuest have?

PathoQuest raised $24.1M across 5 rounds.

How many employees does PathoQuest have?

PathoQuest has 56 employees.

Where is PathoQuest headquarters?

PathoQuest is headquartered in Paris, Ile-de-france, France.

Data and Sources

All figures on this page are taken directly from interviews or are estimates from public sources and proprietary models. Not financial advice. Read full disclaimer.

Claim this profile
PathoQuest Revenue 2024: $5.9M Est. ARR, $24.1M Raised